Concepedia

Ghislaine Perrault

GP

Statistics

Publications

54

Citations

4.4K

H-Index

36

Active since

1986

Affiliations

Laboratoire de Synthèse Organique(Current)

Sanofi (France)

CNS Research (United States)

Sanofi (Turkey)

Ghislaine Perrault is an author at Laboratoire de Synthèse Organique specializing in medicine, pharmacology, and neuropharmacology.

Publications per year

1986–2005

54

Publications

54

Differences in anxiety-related behaviours and in sensitivity to diazepam in inbred and outbred strains of mice

Guy Griebel, Catherine Belzung, Ghislaine Perrault et al. · Psychopharmacology · 2000 · 419 citations

Medicine, Behavioral Sciences, Pharmacology +13

SR141716, a central cannabinoid (CB1) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats

Caroline Cohen, Ghislaine Perrault, C. Voltz et al. · Behavioural Pharmacology · 2002 · 395 citations

Medicine, Neuroscience, Pharmacology +17

Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects.

H. Depoortere, B. Živković, Kennett G. Lloyd et al. · Journal of Pharmacology and Experimental Therapeutics · 1986 · 282 citations

Medicine, Medicinal Chemistry, Pharmacology +16

Nicotine-Associated Cues Maintain Nicotine-Seeking Behavior in Rats Several Weeks after Nicotine Withdrawal: Reversal by the Cannabinoid (CB1) Receptor Antagonist, Rimonabant (SR141716)

Caroline Cohen, Ghislaine Perrault, Guy Griebel et al. · Neuropsychopharmacology · 2004 · 253 citations

Medicine, Neuroscience, Pharmacology +16

Psychopharmacological Profile of Amisulpride: An Antipsychotic Drug with Presynaptic D2/D3 Dopamine Receptor Antagonist Activity and Limbic Selectivity

Ghislaine Perrault, Ronan Depoortère, Eliane Morel et al. · Journal of Pharmacology and Experimental Therapeutics · 1997 · 233 citations

Medicine, Pharmacology, Pharmacotherapy +15

1–5 of 54